Prime Aesthetics Clinic Ltd 10451638 false 2024-04-01 2025-03-31 2025-03-31 The principal activity of the company is that of the provision of beauty treatments. Digita Accounts Production Advanced 6.30.9574.0 true false 10451638 2024-04-01 2025-03-31 10451638 2025-03-31 10451638 core:CurrentFinancialInstruments 2025-03-31 10451638 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 10451638 core:Non-currentFinancialInstruments 2025-03-31 10451638 core:Non-currentFinancialInstruments core:AfterOneYear 2025-03-31 10451638 core:MoreThanFiveYears 1 2025-03-31 10451638 core:FurnitureFittingsToolsEquipment 2025-03-31 10451638 core:OtherPropertyPlantEquipment 2025-03-31 10451638 bus:SmallEntities 2024-04-01 2025-03-31 10451638 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 10451638 bus:FilletedAccounts 2024-04-01 2025-03-31 10451638 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 10451638 bus:RegisteredOffice 2024-04-01 2025-03-31 10451638 bus:Director1 2024-04-01 2025-03-31 10451638 bus:Director2 2024-04-01 2025-03-31 10451638 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 10451638 core:FurnitureFittings 2024-04-01 2025-03-31 10451638 core:FurnitureFittingsToolsEquipment 2024-04-01 2025-03-31 10451638 core:OtherPropertyPlantEquipment 2024-04-01 2025-03-31 10451638 core:PlantMachinery 2024-04-01 2025-03-31 10451638 countries:EnglandWales 2024-04-01 2025-03-31 10451638 2024-03-31 10451638 core:FurnitureFittingsToolsEquipment 2024-03-31 10451638 core:OtherPropertyPlantEquipment 2024-03-31 10451638 2023-04-01 2024-03-31 10451638 2024-03-31 10451638 core:CurrentFinancialInstruments 2024-03-31 10451638 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 10451638 core:CurrentFinancialInstruments core:WithinOneYear core:PreviouslyStatedAmount 2024-03-31 10451638 core:Non-currentFinancialInstruments 2024-03-31 10451638 core:Non-currentFinancialInstruments core:AfterOneYear 2024-03-31 10451638 core:Non-currentFinancialInstruments core:AfterOneYear core:PreviouslyStatedAmount 2024-03-31 10451638 core:MoreThanFiveYears 1 2024-03-31 10451638 core:FurnitureFittingsToolsEquipment 2024-03-31 10451638 core:OtherPropertyPlantEquipment 2024-03-31 10451638 core:PreviouslyStatedAmount 2024-03-31 iso4217:GBP xbrli:pure

Registration number: 10451638

Prime Aesthetics Clinic Ltd

Unaudited Financial Statements

for the Year Ended 31 March 2025

Brebners
Chartered Accountants
Brebners
1 Suffolk Way
Sevenoaks
Kent
TN13 1YL

 

Prime Aesthetics Clinic Ltd

Statement of Financial Position as at 31 March 2025

Note

2025
£

2024
£

Fixed assets

 

Tangible assets

4

20,311

30,201

Current assets

 

Stocks

5

35,164

37,528

Debtors

6

14,996

15,598

Cash at bank and in hand

 

52

47,753

 

50,212

100,879

Creditors: Amounts falling due within one year

7

(43,967)

(35,602)

Net current assets

 

6,245

65,277

Total assets less current liabilities

 

26,556

95,478

Creditors: Amounts falling due after more than one year

7

(182,349)

(195,011)

Net liabilities

 

(155,793)

(99,533)

Capital and reserves

 

Called up share capital

1

1

Retained earnings

(155,794)

(99,534)

Shareholders' deficit

 

(155,793)

(99,533)

For the financial year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and FRS 102 ‘The Financial Reporting Standard Applicable in the UK and Republic of Ireland’.

The directors of Prime Aesthetics Clinic Ltd have elected not to include a copy of the Income Statement within the financial statements, in accordance with the special provisions relating to companies subject to the small companies regime within the Companies Act 2006, s444.

 

Prime Aesthetics Clinic Ltd

Statement of Financial Position as at 31 March 2025

Approved and authorised by the Board on 28 August 2025 and signed on its behalf by:
 

.........................................

Mr T Salahi

Director

.........................................

Mrs F Salahi

Director

Company registration number: 10451638

 

Prime Aesthetics Clinic Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Brebners
1 Suffolk Way
Sevenoaks
Kent
TN13 1YL

The principal activity of the company is that of the provision of beauty treatments.

2

Accounting policies

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' Section 1A and the Companies Act 2006.

Basis of preparation

These financial statements have been prepared using the historical cost convention except any items disclosed in the accounting policies as being shown at fair value and are presented in sterling, which is the functional currency of the entity.

Summary of significant accounting policies

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Going concern

The company made a loss for the year ended 31 March 2025 and had net liabilities at that date amounting to £155,793. The company had net current assets of £6,245 at 31 March 2025 and the directors are hopeful of a return to profitability in the forthcoming year and that the company will continue to be able to meet its obligations.

Having made enquiries the directors have reasonable expectation that the company has adequate resources to remain in operational existence for the foreseeable future. Accordingly, the directors continue to prepare the
financial statements on the going concern basis.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the and provision of beauty treatments in the ordinary course of the company’s activities. Turnover is shown net of value added tax rebates and discounts.

The company recognises revenue at the point that the beauty treatments are provided.

 

Prime Aesthetics Clinic Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Furniture and fixtures

20% straight line

Medical equipment

20% straight line

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the income statement over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

 

Prime Aesthetics Clinic Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

The average number of persons employed by the company during the year was 6 (2024 - 2).

4

Tangible assets

Furniture and fixtures
£

Medical equipment
£

Total
£

Cost or valuation

At 1 April 2024

52,545

22,029

74,574

At 31 March 2025

52,545

22,029

74,574

Depreciation

At 1 April 2024

34,391

9,982

44,373

Charge for the year

6,856

3,034

9,890

At 31 March 2025

41,247

13,016

54,263

Carrying amount

At 31 March 2025

11,298

9,013

20,311

At 31 March 2024

18,154

12,047

30,201

5

Stocks

2025
£

2024
£

Stock

35,164

37,528

 

Prime Aesthetics Clinic Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

6

Debtors

2025
£

2024
£

Trade debtors

2,900

3,244

Other debtors

12,096

12,354

14,996

15,598

7

Creditors

Creditors: amounts falling due within one year

Note

2025
£

2024
£

Loans and borrowings

8

27,932

11,617

Taxation and social security

 

6,357

14,195

Other creditors

 

9,678

9,790

 

43,967

35,602

Creditors: amounts falling due after more than one year

Note

2025
£

2024
£

Loans and borrowings

8

182,349

195,011

2025
£

2024
£

Due after more than five years

After more than five years by instalments

88,632

161,082

-

 

Prime Aesthetics Clinic Ltd

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

8

Loans and borrowings

Current loans and borrowings

2025
£

2024
£

Bank loans

12,199

11,617

Bank overdrafts

6,779

-

Other loan

8,954

-

27,932

11,617

Non-current loans and borrowings

2025
£

2024
£

Bank loans

182,349

195,011

9

Transactions with directors

At 31 March 2025 an amount of £12,096 (2024: £12,354) was due from the directors. During the year there were advances of £48,780 and repayments of £49,559. £521 of interest has been charged at 2.25% and there are no terms in place.